Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Eiger completes enrollment in Phase II of Lambda

Alicia Parker
September 1, 2017 3:08 PM UTC

Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) completed enrollment of 33 patients in the Phase II LIMT HDV trial of Lambda (BMS-914143, Pegylated Interferon Lambda) to treat chronic HDV infection. The open-label, international trial is evaluating 120 and 180 µg subcutaneous Lambda once weekly for 48 weeks. The primary endpoint is change from baseline in HDV viral load at 48 and 72 weeks...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Bristol Myers Squibb Co.

Eiger Biopharmaceuticals Inc.